Idogen AB - ESG Rating & Company Profile powered by AI
Comprehensive ESG assessment of Idogen AB can be reached by signing in. The webpage of Idogen AB was prepared by All Street Sevva using proprietary NLP. The page is a free E,S&G assessment covering Idogen AB.
Idogen AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | Idogen AB | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Idogen AB have an accelerator or VC vehicle to help deliver innovation?
Does Idogen AB disclose current and historical energy intensity?
Does Idogen AB report the average age of the workforce?
Does Idogen AB reference operational or capital allocation in relation to climate change?
Does Idogen AB disclose its ethnicity pay gap?
Does Idogen AB disclose cybersecurity risks?
Does Idogen AB offer flexible work?
Does Idogen AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Idogen AB disclose the number of employees in R&D functions?
Does Idogen AB conduct supply chain audits?
Does Idogen AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Idogen AB conduct 360 degree staff reviews?
Does Idogen AB disclose the individual responsible for D&I?
Does Idogen AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Idogen AB disclose current and / or historical scope 2 emissions?
Does Idogen AB disclose water use targets?
Does Idogen AB have careers partnerships with academic institutions?
Did Idogen AB have a product recall in the last two years?
Does Idogen AB disclose incidents of discrimination?
Does Idogen AB allow for Work Councils/Collective Agreements to be formed?
Has Idogen AB issued a profit warning in the past 24 months?
Does Idogen AB disclose parental leave metrics?
Does Idogen AB disclose climate scenario or pathway analysis?
Does Idogen AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Idogen AB disclose the pay ratio of women to men?
Does Idogen AB support suppliers with sustainability related research and development?
Does Idogen AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Idogen AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Idogen AB involved in embryonic stem cell research?
Does Idogen AB disclose GHG and Air Emissions intensity?
Does Idogen AB disclose its waste policy?
Does Idogen AB report according to TCFD requirements?
Does Idogen AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Idogen AB disclose energy use targets?
Does Idogen AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Idogen AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Idogen AB
These potential risks are based on the size, segment and geographies of the company.
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden.